The Advisory Board Company (NASDAQ:ABCO)
CAPS Rating:
The Company provides best practices research, decision support tools and analysis to the health care industry in the United States.
The Company provides best practices research, decision support tools and analysis to the health care industry in the United States.
Recs
Ridiculously overvalued. Trading at 25x EV/EBITDA, 4x EV/Rev, 7x book value, 4x sales, 64x trailing earnings, 33x forward earnings.Come on now, this isn't a premium company.